Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • tjahns
    Junior Member
    • Jul 2008
    • 9

    Convert euler-sr output to amos-bank

    I'm contemplating using the amos validator to get an impression how useful the euler-sr output really is. But I don't see any obvious way to get the mapping of reads to the generated contig.

    Does anyone here know euler-sr or amos well? I'm sort of stuck because if said mapping is not available I don't think I can construct a usable amos-bank.

    Thanks for any pointers I might have missed.
  • mchaisso
    Member
    • Apr 2008
    • 84

    #2
    euler-sr -> amos

    If you post a link of what sort of format you want to see, I'll see if I can output that along with an assembly (and supply a converter for finished assemblies).

    -mark

    Comment

    • mchaisso
      Member
      • Apr 2008
      • 84

      #3
      also, let me know what you mean by useful-- it will have impact on some development I do over the next couple of weeks.

      Comment

      • tjahns
        Junior Member
        • Jul 2008
        • 9

        #4
        Format for using Amos tools

        The best format would probably be an amos/celera assembler message file. You might want to have a look at what velvet does (which can produce such and .afg-file) in this respect.

        Comment

        • tjahns
          Junior Member
          • Jul 2008
          • 9

          #5
          Oh and useful refers to using the amosvalidate tool for validation without a reference.

          Comment

          Latest Articles

          Collapse

          • SEQadmin2
            Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
            by SEQadmin2


            Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

            The systematic characterization of the human proteome has
            ...
            Today, 11:48 AM
          • SEQadmin2
            Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
            by SEQadmin2



            Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
            ...
            07-09-2026, 11:10 AM
          • SEQadmin2
            Cancer Drug Resistance: The Lingering Barrier to Rising Survival
            by SEQadmin2



            Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

            There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
            07-08-2026, 05:17 AM

          ad_right_rmr

          Collapse

          News

          Collapse

          Topics Statistics Last Post
          Started by SEQadmin2, Today, 11:10 AM
          0 responses
          8 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-13-2026, 10:26 AM
          0 responses
          30 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-09-2026, 10:04 AM
          0 responses
          39 views
          0 reactions
          Last Post SEQadmin2  
          Started by SEQadmin2, 07-08-2026, 10:08 AM
          0 responses
          25 views
          0 reactions
          Last Post SEQadmin2  
          Working...